Benjamin B.

Benjamin B. has a strong background in the biotechnology and venture capital industries. Benjamin currently holds the position of Principal Scientist at Odyssey Therapeutics, where they started in July 2022. Prior to this, Benjamin was a Venture Partner at Hyperplane Venture Capital since March 2018. Benjamin also worked as a Data Science professional at Newco/Inzen/Sonata (Flagship Pioneering) from April 2021 to July 2022. Earlier in their career, Benjamin gained experience as a Graduate Student Intern at MPM Capital from December 2018 to July 2019. Benjamin began their career at Adnexus Therapeutics (Bristol-Myers Squibb) in July 2009 and worked there until August 2014 in a role also called Adnexus Therapeutics.

Benjamin B. holds a Bachelor of Arts (A.B.) degree from Dartmouth College. Benjamin is also a Doctor of Philosophy (Ph.D.) in Computational and Systems Biology from Boston University School of Medicine.